[HTML] sciencedirect.com

[HTML][HTML] A mesoporous polydopamine-derived nanomedicine for targeted and synergistic treatment of inflammatory bowel disease by pH-Responsive drug release …

H Guan, Z Xu, G Du, Q Liu, Q Tan, Y Chen, S Chen… - Materials Today Bio, 2023 - Elsevier
Repurposing clinically approved drugs to construct novel nanomedicines is currently a very
attractive therapeutic approach. Selective enrichment of anti-inflammatory drugs and …
被引用次数：16 相关文章

A mesoporous polydopamine-derived nanomedicine for targeted and synergistic treatment of inflammatory bowel disease by pH-Responsive drug release and ROS …

H Guan, Z Xu, G Du, Q Liu, Q Tan… - Materials …, 2023 - pubmed.ncbi.nlm.nih.gov
Repurposing clinically approved drugs to construct novel nanomedicines is currently a very
attractive therapeutic approach. Selective enrichment of anti-inflammatory drugs and …
[HTML] nih.gov

[HTML][HTML] A mesoporous polydopamine-derived nanomedicine for targeted and synergistic treatment of inflammatory bowel disease by pH-Responsive drug release …

H Guan, Z Xu, G Du, Q Liu, Q Tan, Y Chen… - Materials Today …, 2023 - ncbi.nlm.nih.gov
Repurposing clinically approved drugs to construct novel nanomedicines is currently a very
attractive therapeutic approach. Selective enrichment of anti-inflammatory drugs and …